Impact of UniversalHaemophilus influenzaeType b Vaccination Starting at 2 Months of Age in the United States: An Economic Analysis
- 1 October 2002
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 110 (4) , 653-661
- https://doi.org/10.1542/peds.110.4.653
Abstract
Read the full review for this F1000Prime recommended article: Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.Keywords
This publication has 36 references indexed in Scilit:
- Cost of Illness of Epilepsy in the US: Comparison of Patient-Based and Population-Based EstimatesNeuroepidemiology, 2000
- Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in FranceVaccine, 1996
- Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, SpainVaccine, 1995
- Invasive Haemophilus influenzae Type b Disease in Children <5 Years of Age in Minnesota and in Dallas County, Texas, 1983-1984The Journal of Infectious Diseases, 1992
- InvasiveHaemophilus influenzaeinfections among children in Rochester, Minnesota: a population-based studyPaediatric and Perinatal Epidemiology, 1990
- Cost-benefit analysis of Haemophilus influenzae type b preventionThe Pediatric Infectious Disease Journal, 1990
- Primary invasive Haemophilus influenzae type b disease: A population-based assessment of risk factorsThe Journal of Pediatrics, 1986
- Risk factors for primary invasive Haemophilus influenzae disease: Increased risk from day care attendance and school-aged household membersThe Journal of Pediatrics, 1985
- Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type bThe Journal of Pediatrics, 1981
- Haemophilus influenzaeMeningitisNew England Journal of Medicine, 1979